Key stats
About CMF CSI Vaccine and Biotechnology Exchange Traded Fund Units
Home page
Inception date
Mar 15, 2023
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
China Merchants Fund Management Co., Ltd.
ISIN
CNE100005ST6
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks98.39%
Health Technology84.36%
Process Industries3.98%
Producer Manufacturing3.37%
Transportation2.28%
Commercial Services2.05%
Retail Trade1.60%
Finance0.76%
Bonds, Cash & Other1.61%
Cash1.61%
Stock breakdown by region
Asia96.98%
Europe3.02%
North America0.00%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
561920 invests in stocks. The fund's major sectors are Health Technology, with 84.36% stocks, and Process Industries, with 3.98% of the basket. The assets are mostly located in the Asia region.
561920 top holdings are Chongqing Zhifei Biological Products Co., Ltd. Class A and Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A, occupying 10.34% and 8.58% of the portfolio correspondingly.
No, 561920 doesn't pay dividends to its holders.
561920 shares are issued by China Merchants Bank Co., Ltd. under the brand China Merchants. The ETF was launched on Mar 15, 2023, and its management style is Passive.
561920 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
561920 follows the CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
561920 invests in stocks.